ADAMTS‐13 and von Willebrand factor: a dynamic duo

por South, K., Lane, D. A.
Publicado 2017

Conformational quiescence of ADAMTS‐13 prevents proteolytic promiscuity

por South, K., Freitas, M. O., Lane, D. A
Publicado 2016

Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack

por CRAWLEY, J T B, LANE, D A, WOODWARD, M, RUMLEY, A, LOWE, G D O
Publicado 2008

Enhanced activity of an ADAMTS‐13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic stroke

por South, K., Denorme, F., Salles‐Crawley, I. I., De Meyer, S. F., Lane, D. A.
Publicado 2018

Stop and Go: Barriers and Facilitators to Care Home Research

por Ritchie, Leona A., Gordon, A. L., Penson, P. E., Lane, D. A., Akpan, A.
Publicado 2022

Further characterization of ADAMTS-13 inactivation by thrombin

por LAM, J K, CHION, C K N K, ZANARDELLI, S, LANE, D A, CRAWLEY, J T B
Publicado 2007

Proteolysis of the endothelial cell protein C receptor by neutrophil proteinase 3

por VILLEGAS-MENDEZ, A, MONTES, R, AMBROSE, L R, WARRENS, A N, LAFFAN, M, LANE, D A
Publicado 2007

Short-Term Effects of Screening for Cardiovascular Risk in the Deaf Community: A Pilot Study

por Patel, J. V., Gill, P. S., Chackathayil, J., Ojukwu, H., Stemman, P., Sheldon, L., Meelu, S., Lane, D. A., Tracey, I., Lip, G. Y. H., Hughes, E. A.
Publicado 2011

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study

por Alings, M., Smit, M. D., Moes, M. L., Crijns, H. J. G. M., Tijssen, J. G. P., Brügemann, J., Hillege, H. L., Lane, D. A., Lip, G. Y. H., Smeets, J. R. L. M., Tieleman, R. G., Tukkie, R., Willems, F. F., Vermond, R. A., Van Veldhuisen, D. J., Van Gelder, I. C.
Publicado 2013